Early stage disease GnRH antagonists IX Flashcards
1
Q
MOA degarelix
A
- reversibly bind GnRH-R on pituary gland
- decrease testosterone to castration levels
2
Q
Advantage degarelix
A
- castration levels reached in 7 days /<
- elminate risk tumour flare + need for antiandrogen
3
Q
Avaialbility + dosage adm degarelix
A
- degarelix equivalent leuprolide
- advanced PCa
- 80mg / 120mg vials - SC
- starting dose 240mg followed 80mg per month
- starting dose split in 2 120mg injections
4
Q
Adverse effects degeralix
A
- inj site rxns
- LFT elevations
- osteoperosis
ADVICE CA + VIT D supp